Concepedia

John M. Hatcher

JM

Statistics

Publications

25

Citations

1.6K

H-Index

19

Active since

2003

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Longwood University

Boston Children's Hospital

Stanford University

John M. Hatcher is an author at Dana-Farber Cancer Institute specializing in drug discovery, pharmacology, and medicine.

Publications per year

2003–2023

25

Publications

25

Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development

Katherine A. Donovan, Fleur M. Ferguson, Jonathan W. Bushman et al. · Cell · 2020 · 371 citations · Full text

Engineering, Bioengineering, Biotechnology +2

Brain Penetrant LRRK2 Inhibitor

Hwan Geun Choi, Jinwei Zhang, Xianming Deng et al. · ACS Medicinal Chemistry Letters · 2012 · 133 citations

Medicine, Neuroscience, Pharmacology +16

SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform

John M. Hatcher, Guowei Wu, Chuyue Zeng et al. · Cell chemical biology · 2018 · 131 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Crystal structure of human IRAK1

Li Wang, Qi Qiao, Ryan Ferrao et al. · Proceedings of the National Academy of Sciences · 2017 · 86 citations · Full text

Life Sciences, Immunology, Medicinal Chemistry +13

Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8

John M. Hatcher, Eric S. Wang, Liv Johannessen et al. · ACS Medicinal Chemistry Letters · 2018 · 84 citations · Full text

Pharmacy, Chemical Biology, Medicinal Chemistry +15

1–5 of 25